Clarity Misses July Target Shifts to August Floor Deadline
The CLARITY Act failed to hit its July 4 milestone. With August 7 looming, Senate leadership faces a narrow window to...
Ways To Use Reward Points Effectively
Learn effective ways to use your reward points to get the most out of your credit card benefits. Start maximizing your rewards now!
23,429 articles
Palo Alto Soared: Should Investors Rotate to CrowdStrike
Palo Alto Networks has surged about a month’s worth of gains, fueling a debate on whether to book profits and rotate ...
Strategy Binance: Who’s Sitting on Unrealized Losses?
Strategy launched its largest BTC sale this week, intensifying the debate over unrealized losses among major crypto h...
AAOI Soared 251%, Quietly Doubling Investors’ Money
Applied Optoelectronics surged 251% year-to-date on soaring AI data-center demand, while the Invesco Semiconductors E...
Volkswagen’s Suggests ‘More Intelligent’ Path to Turnaround
Volkswagen signals a smarter-cost strategy to turn around its performance, prioritizing efficiency over plant shutdow...
Buy, Sell or Hold: MSFT AI Capex Surge Sparks View
Microsoft faces a high-growth, high-capex path as AI investment accelerates. Here is a fresh take on whether to buy, ...
Abbott Labs Pfizer: Which Is the Bigger Value Trap Now
Abbott Laboratories and Pfizer both delivered solid Q1 2026 numbers, yet the market sentiment diverged. Abbott slumpe...
Three Income Stocks That More Than Cover the COLA in 2026
As the 2026 COLA rises to 2.8%, investors turn to steady income stocks that more than cover the gap. A trio of picks ...
Billionaire Richard Branson Says Morning Routines Don’t Work
Richard Branson is pushing back on the idea that waking up at 5 a.m. guarantees success. He argues a sustainable rout...
Dell Falls 14%, Super Micro Slide as AI Stocks Give Back
Dell shares tumbled about 14% as investors pulled back from AI hardware names, with HPE and Super Micro also sliding....
Point Closes $508.6M Securitization, Largest to Date
Point closes $508.6m securitization, the largest HEI-backed deal to date, as institutional buyers pile into home equi...
Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status